Related Experiment Video
Updated: Oct 15, 2025

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
PPARβ down-regulation is involved in high glucose-induced endothelial injury via acceleration of nitrative stress
Chuang Yang1, Lai Xue2, Yang Wu3
1Department of Pharmacology, Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Key Laboratory of Drug Metabolism, College of Pharmacy, Chongqing Medical University, Chongqing 400016, PR China.
Abstract:
Endothelial injury plays a vital role in vascular lesions from diabetes mellitus (DM). Therapeutic targets against endothelial damage may provide critical venues for the treatment of diabetic vascular diseases. Peroxisome proliferator-activated receptor β (PPARβ) is a crucial regulator in DM and its complications. However, the molecular signal mediating the roles of PPARβ in DM-induced endothelial dysfunction is not fully understood. The impaired endothelium-dependent relaxation and destruction of the endothelium structures appeared in high glucose incubated rat aortic rings. A high glucose level significantly decreased the expression of PPARβ and endothelial nitric oxide synthase (eNOS) at the mRNA and protein levels, and reduced the concentration of nitric oxide (NO), which occurred in parallel with an increase in the expression of inducible nitric oxide synthase (iNOS) and 3-nitrotyrosine. The effect of high glucose was inhibited by GW0742, a PPARβ agonist. Both GSK0660 (PPARβ antagonist) and NG-nitro-l-arginine-methyl ester (NOS inhibitor) could reverse the protective effects of GW0742. These results suggest that the activation of nitrative stress may, at least in part, mediate the down-regulation of PPARβ in high glucose-impaired endothelial function in rat aorta. PPARβ-nitrative stress may hold potential in treating vascular complications from DM.
Insights
High glucose impairs blood vessel function by reducing Peroxisome proliferator-activated receptor beta (PPARβ) and nitric oxide (NO) production. Activating PPARβ with GW0742 protects against this damage, suggesting a therapeutic target for diabetic vascular disease.
Area of Science:
- Vascular Biology
- Endocrinology
- Diabetology
Background:
- Endothelial injury is central to diabetic vascular complications.
- Peroxisome proliferator-activated receptor beta (PPARβ) is implicated in diabetes mellitus (DM) and its complications.
- The precise molecular mechanisms of PPARβ in DM-induced endothelial dysfunction require further elucidation.
Purpose of the Study:
- To investigate the role of PPARβ in high glucose-induced endothelial dysfunction.
- To explore the relationship between PPARβ, nitric oxide (NO) production, and nitrative stress in diabetic conditions.
- To evaluate the therapeutic potential of PPARβ activation in mitigating endothelial damage.
Main Methods:
- Rat aortic rings were incubated under high glucose conditions.
- Expression levels of PPARβ, endothelial nitric oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) were measured at mRNA and protein levels.
- Nitric oxide (NO) and 3-nitrotyrosine concentrations were assessed.
- The effects of GW0742 (PPARβ agonist), GSK0660 (PPARβ antagonist), and N-G-nitro-L-arginine methyl ester (NOS inhibitor) were evaluated.
Main Results:
- High glucose impaired endothelium-dependent relaxation and endothelial structure.
- High glucose significantly decreased PPARβ and eNOS expression while increasing iNOS and 3-nitrotyrosine.
- Reduced NO concentration was observed under high glucose conditions.
- GW0742 treatment reversed high glucose-induced endothelial dysfunction.
- GSK0660 and NOS inhibition counteracted the protective effects of GW0742.
Conclusions:
- High glucose-induced endothelial dysfunction in rat aorta involves the down-regulation of PPARβ, potentially mediated by nitrative stress.
- PPARβ activation demonstrates protective effects against high glucose-induced endothelial damage.
- Targeting the PPARβ-nitrative stress pathway may offer a novel therapeutic strategy for diabetic vascular complications.
Related Concept Videos
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Regulation of Angiogenesis and Blood Supply
GPCRs Regulate Adenylyl Cylase Activity
Nitric Oxide Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

